Catalyst
Slingshot members are tracking this event:
VolitionRx Announces CE Marks for Two NuQ Blood Assays for Detection of Colorectal Cancer
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| VNRX | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 07, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Ce Mark, Nuq Blood Assays, Colorectal Cancer, Nuq V001, Nuq T003
